查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1702366

全球免疫测定市场 - 2025-2033

Global Immunoassay Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球免疫测定市场规模达到 368.7 亿美元，预计到 2033 年将达到 686 亿美元，在 2025-2033 年预测期内的复合年增长率为 7.1%。

免疫测定是一种利用抗原抗体亲和力来区分和量化生物样本中感兴趣的分子的生物分析技术。免疫测定是一种能够快速、准确地识别特定化合物的实验室程序。

免疫测定广泛应用于临床诊断、药物研发和食品检测等各个领域，以识别和测量样本中特定物质的存在。

市场动态：

驾驶员和约束装置

不断创新推出先进的免疫分析仪器

免疫测定市场受到多种因素的推动。推动市场发展的重大因素之一包括不断增加的创新和先进免疫分析仪器的推出。市场的主要参与者正在引入先进的系统，以满足寻求先进、精确解决方案的专业人士的需求。例如，2023 年 7 月，西门子医疗推出了用于临床化学和免疫测定测试的 Atellica CI 分析仪。此外，2023年8月，法邦推出了最新的化学发光免疫分析系统Shine i8000/9000。这款高速全自动分析仪在美国临床化学协会（AACC）临床实验室博览会暨会议上展示，拥有每小时900次测试的超高吞吐量，采用整合紧凑的设计，性能稳定。

同样在2022年11月，Gethin Biotech在MEDICA推出了新型MAGICAL 6000化学发光免疫分析仪。它是一款紧凑、创新的化学发光免疫分析仪，非常适合需要一步化学发光解决方案的中高工作流程实验室。

这些公司正在推出具有特定功能的免疫分析系统。例如，2024 年 7 月，HU Group Holdings Inc. 及其全资子公司 Fujirebio 宣布推出适用于全自动、随机存取 LUMIPULSE G 免疫分析系统的 Lumipulse G GFAP 检测。仅供研究使用（RUO）的检测目前已在日本和美国推出。

仪器和试剂成本高

预计仪器和试剂的高成本将对免疫测定市场的成长构成重大挑战。免疫测定是临床和研究环境中必不可少的诊断工具，需要专门的、通常昂贵的仪器，以及稳定的检测试剂供应。这些成本可能过高，特别是对于预算有限的发展中地区的小型实验室或医疗机构。因此，维护和操作免疫测定係统的财务负担可能会导致采用率下降，从而阻碍市场成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 按产品类型分类的程式码片段
  • 样本片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 不断创新推出先进的免疫分析仪器
      • 慢性病和传染病发生率上升
    • 限制
      • 仪器和试剂成本高昂
      • 复杂的检测程序
    • 机会
      • 加强研发
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：免疫分析市场（按类型）

  • 酵素连结免疫吸附试验
  • 放射免疫分析（RIA）
  • 萤光免疫分析（FIA）
  • 化学发光免疫分析（CLIA）
  • 快速检测
  • 其他的

第六章：免疫分析市场（依产品类型）

  • 试剂和试剂盒
    • ELISA 试剂和试剂盒
    • 快速检测试剂和试剂盒
    • ELISPOT 试剂与试剂盒
    • 蛋白质印迹试剂和试剂盒
    • 其他的
  • 分析器
    • 开放式系统
    • 封闭式系统
  • 软体与服务

第七章：免疫分析市场（按样本）

  • 血
  • 唾液
  • 尿
  • 其他

第 8 章：免疫分析市场（按应用）

  • 治疗药物监测
  • 药物研发
  • 疾病诊断
    • 传染病
    • 癌症
    • 内分泌学
    • 自体免疫疾病
    • 心臟病学
    • 血液学
    • 其他的
  • 其他

第 9 章：免疫分析市场（按最终用户划分）

  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 学术研究中心
  • 其他的

第 10 章：免疫测定市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十二章：公司简介

  • Beckman Coulter, Inc.
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc
  • Abbott
  • DiaSorin SpA
  • BD
  • Thermo Fisher Scientific Inc.
  • Merck KGaA

第十三章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: CD1273

The global immunoassay market reached US$ 36.87 billion in 2024 and is expected to reach US$ 68.60 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033.

Immunoassay is a bioanalytical technique that utilizes antigen-antibody affinity to differentiate and quantify molecules of interest in biological samples. Immunoassays are laboratory procedures that enable the rapid and precise identification of specific compounds.

Immunoassays are widely used in various fields, including clinical diagnostics, drug discovery, and food testing, to identify and measure the presence of specific substances in a sample.

Market Dynamics: Drivers & Restraints

Increasing Innovation and Launches of Advanced Immunoassay Instruments

The immunoassay market is driven by several factors. One of the significant factors driving the market include increasing innovation and launches of advanced immunoassay instruments. Key players in the market are introducing advanced systems to meet the needs of professionals seeking solutions that are advanced and precise. For instance, in July 2023, Siemens Healthineers introduced the Atellica CI Analyzer for clinical chemistry and immunoassay testing. Also, in August 2023, Fapon launched its latest chemiluminescence immunoassay system, Shine i8000/9000. The high-speed and fully automated analyzer has an ultra-high throughput of 900 tests per hour and features an integrated and compact design with stable performance at the American Association of Clinical Chemistry (AACC) Clinical Lab Expo and Meeting.

Similarly in November 2022, Gethin Biotech launched the new MAGICAL 6000 chemiluminescence immunoassay Analyzer at MEDICA. It is a compact and innovative chemiluminescence immunoassay analyzer that is ideal for mid to high-workflow laboratories that require a one-step chemiluminescence solution.

The companies are introducing immunoassay systems with specific features. For instance, in July 2024, H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G GFAP assay for the fully automated, random-access LUMIPULSE G immunoassay systems. The Research Use Only (RUO) assay is now available in Japan and the United States.

High Cost of Instruments & Reagents

The high cost of instruments and reagents is anticipated to pose a significant challenge to the growth of the immunoassay market. Immunoassays, which are essential diagnostic tools in clinical and research settings, require specialized and often expensive instruments, as well as a consistent supply of reagents for testing. These costs can be prohibitive, especially for smaller laboratories or healthcare facilities in developing regions with limited budgets. As a result, the financial burden of maintaining and operating immunoassay systems could lead to a slower adoption rate, hindering market growth.

Segment Analysis

The global immunoassay market is segmented based on type, product type, specimen, application, end-user, and region.

Type:

ELISA in the type segment is expected to dominate the immunoassay market.

The ELISA segment is expected to hold the major market share over the forecast period. ELISA is an immunological assay commonly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Some examples include diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum.

The ELISA technique is most frequently used due to its ability and efficiency in detecting and quantifying biomarkers. A wide range of conditions, from bacterial and viral infections (like Lyme disease and HIV) to endocrine conditions, like thyroid disease can be detected using ELISA which makes it more preferable over other immunoassays. Several existing and emerging market players are adopting strategies such as partnerships and collaborations with each other to expand their businesses which is contributing to the segment's expansion.

Many key players are launching efficient and advanced ELISA kits that help in detecting disease conditions. For instance, in February 2023, Charles River Laboratories International, Inc. announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics.

Additionally, in February 2024, Krishgen Biosystems is proud to announce the launch of our newest product, the CRM197 ELISA. This kit is designed with a direct sandwich assay format to facilitate accurate and efficient detection of CRM197 with better specificity and sensitivity compared to conventional ELISA kits which employ only one antibody. Double antibodies are used in this kit.CRM197 ELISA kit is used as an analytical tool for the quantitative determination of CRM197 in culture supernatants, vaccines and other biological preparations.

Geographical Analysis

North America is expected to dominate the immunoassay market.

North America holds the largest market share and is expected to continue throughout the forecast period. The rise in demand for diagnostics related to chronic diseases and the availability of technologically advanced diagnostic techniques are expected to propel market growth over the forecast period.

The rising prevalence of infectious diseases and other diseases such as cardiovascular diseases, and cancer among others is creating an opportunity for local market players to boost their sales of diagnostic products. The incidence of diseases such as diabetes, cancer, and infectious diseases increases the demand for diagnostic tests, especially immunoassays, for early detection and observation. Collaborations among academic institutions, research groups, and companies allow for the exchange of knowledge and resources, which boosts market innovation.

The key market players are introducing innovative solutions with advanced features which could increase the region's market expansion. For instance, in July 2024, Beckman Coulter Diagnostics launched the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer. Utilizing Beckman Coulter's common reagents and consumables across its scalable clinical chemistry and immunoassay portfolio, the DxC 500i Analyzer enables commutable patient results, offering hospitals and healthcare networks strategic benefits in patient care and inventory management. Additionally, the increasing research and development and the increasing drug discovery in the region are also expected to propel the market growth.

Competitive Landscape

The global market players in the immunoassay market include Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, BioMerieux SA, Bio-Rad Laboratories, Inc., Abbott, DiaSorin S.p.A., BD, Thermo Fisher Scientific Inc., and Merck KGaA, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global immunoassay market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Product Type
  • 2.5. Snippet by Specimen
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Innovation and Launches of Advanced Immunoassay Instruments
      • 3.1.1.2. Rising Prevalence of Chronic & Infectious Diseases
    • 3.1.2. Restraints
      • 3.1.2.1. The High Cost of Instruments & Reagents
      • 3.1.2.2. Complex Assay Procedures
    • 3.1.3. Opportunity
      • 3.1.3.1. Increasing Research and Development
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Immunoassay Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. ELISA*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Radioimmunoassay (RIA)
  • 5.4. Fluorescence Immunoassays (FIA)
  • 5.5. Chemiluminescence Immunoassays (CLIA)
  • 5.6. Rapid Assays
  • 5.7. Others

6. Immunoassay Market, By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Reagents & kits*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. ELISA Reagents & Kits
    • 6.2.4. Rapid Test Reagents & Kits
    • 6.2.5. ELISPOT Reagents & Kits
    • 6.2.6. Western Blot Reagents & Kits
    • 6.2.7. Others
  • 6.3. Analyzers
    • 6.3.1. Open-ended Systems
    • 6.3.2. Closed-ended Systems
  • 6.4. Software & Services

7. Immunoassay Market, By Specimen

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 7.1.2. Market Attractiveness Index, By Specimen
  • 7.2. Blood*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Saliva
  • 7.4. Urine
  • 7.5. Other

8. Immunoassay Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Therapeutic Drug Monitoring*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Drug Discovery
  • 8.4. Disease Diagnosis
    • 8.4.1. Infectious Disease
    • 8.4.2. Cancer
    • 8.4.3. Endocrinology
    • 8.4.4. Autoimmune Disorders
    • 8.4.5. Cardiology
    • 8.4.6. Hematology
    • 8.4.7. Others
  • 8.5. Other

9. Immunoassay Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Blood Banks
  • 9.4. Clinical Laboratories
  • 9.5. Pharmaceutical and Biotech Companies
  • 9.6. Academic Research Centers
  • 9.7. Others

10. Immunoassay Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Beckman Coulter, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. F. Hoffmann-La Roche Ltd
  • 12.3. Siemens Healthineers AG
  • 12.4. BioMerieux SA
  • 12.5. Bio-Rad Laboratories, Inc
  • 12.6. Abbott
  • 12.7. DiaSorin S.p.A.
  • 12.8. BD
  • 12.9. Thermo Fisher Scientific Inc.
  • 12.10. Merck KGaA

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us